X0306 4 2016-01-04 0 0001444380 NEVRO CORP NVRO 0001639099 Alleavitch Doug C/O NEVRO CORP. 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065 0 1 0 0 VP, Quality and Operations Common Stock 2016-01-04 4 S 0 300 65.8633 D 12170 D Common Stock 2016-01-04 4 S 0 700 66.7671 D 11470 D Common Stock 2016-01-04 4 S 0 500 65.9120 D 7704 I By spouse Common Stock 2016-01-04 4 S 0 1014 66.7179 D 6690 I By spouse The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $65.45 to $66.35, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Includes 470 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 13, 2015. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $66.49 to $67.04, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The sale was effected pursuant to the Reporting Person's spouse's Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $65.38 to $66.29, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $66.41 to $67.06, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. /s/ Andrew Galligan, as Attorney-in-Fact for Doug Alleavitch 2016-01-06